Showing results (1041-1050 of 1,183) with videos related to
Sort By:
Pageof 119
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 2, 2020
Tet1 Isoforms Differentially Regulate Gene Expression, Synaptic Transmission, and Memory in the Mammalian BrainC B Greer, J Wright, J D Weiss, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2008
U.S. Food and Drug Administration approval: panitumumab for epidermal growth factor receptor-expressing metastatic colorectal carcinoma with progression following fluoropyrimidine-, oxaliplatin-, and irinotecan-containing chemotherapy regimensRuthann M Giusti, Kaushikkumar Shastri, Anne M Pilaro, et al.Contemporary Clinical Trials|January 22, 2025
Optimizing retention strategies for opioid use disorder pharmacotherapy: The retention phase of the CTN-0100 trial (RDD)Matisyahu Shulman, Sarah Meyers-Ohki, Patricia Novo, et al.Psychiatric Services (Washington, D.C.)|May 3, 2011
International variation in treatment procedures for ADHD: social context and recent trendsStephen P Hinshaw, Richard M Scheffler, Brent D Fulton, et al.Neurology|May 23, 2008
Late-onset hereditary axonal neuropathiesC L Bennett, V H Lawson, K L Brickell, et al.The American Journal on Addictions|December 5, 2022
Effects of a trauma-informed mindful recovery program on comorbid pain, anxiety, and substance use during primary care buprenorphine treatment: A proof-of-concept studyZev Schuman-Olivier, Thomas Fatkin, Timothy B Creedon, et al.Annals of Human Genetics|December 24, 2013
The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addictionToni-Kim Clarke, Amy R D Weiss, Thomas N Ferarro, et al.Contemporary Clinical Trials|April 24, 2024
Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trialMatisyahu Shulman, Scott Provost, Kaitlyn Ohrtman, et al.Journal of the Royal Society, Interface|May 27, 2020
Paradoxical aortic stiffening and subsequent cardiac dysfunction in Hutchinson-Gilford progeria syndromeS-I Murtada, Y Kawamura, A W Caulk, et al.Biorxiv : the Preprint Server for Biology|November 24, 2025
Single-cell and Spatial Omics Reveals Region-Specific Plasticity and Therapeutic Vulnerabilities in Metastatic High-Risk NeuroblastomaLai Man Natalie Wu, Janet L Oblinger, Dazhuan Xin, et al.Pageof 119